Behavioral AI to Predict and Increase Peritoneal Dialysis Uptake

RecruitingOBSERVATIONAL
Enrollment

3,000

Participants

Timeline

Start Date

September 1, 2024

Primary Completion Date

August 31, 2025

Study Completion Date

December 31, 2025

Conditions
Chronic Kidney Disease
Interventions
OTHER

Predicting choice of dialysis

"Language data collected using survey 1, will be analyzed using Scaled Insights Behavioral AI solution to identify personality attributes and values. The resulting individual scores will be plotted on a graph and be used to identify specific personality clusters of patients.~Participants will respond to a survey that utilizes open and closed ended questions, asking broad questions about kidney failure and associated behaviors (e.g. diet, attitudes towards treatment). The open-ended questions will gather a natural language sample of 100-300 words whilst closed questions will capture data using Likert scale and multiple-choice responses.~The open-ended questions will gather a natural language sample of 100-300 words for analysis using Scaled Insights Behavioral AI approach. This language sample will be analyzed using Scaled Insights Behavioral AI system to identify personality attributes and values. Patients will also be asked their likelihood of selecting PD over HD."

BEHAVIORAL

Behavioral nudges

"Patients with Chronic Kidney Disease, participants will be provided with their predicted personalized nudge to increase their likelihood of either maintaining their choice of peritoneal dialysis, or switching from hemodialysis to peritoneal dialysis.~Participants will respond to a survey that utilizes open and closed ended questions, asking broad questions about kidney failure and associated behaviors (e.g. diet, attitudes towards treatment). The open-ended questions will gather a natural language sample of 100-300 words whilst closed questions will capture data using Likert scale and multiple-choice responses."

Trial Locations (1)

75230

RECRUITING

Dallas Renal Group, Dallas

All Listed Sponsors
collaborator

Dallas Renal Group

UNKNOWN

collaborator

The Leeds Teaching Hospitals NHS Trust

OTHER

collaborator

Suffolk and North East Essex NHS Trust

UNKNOWN

lead

Scaled Insights

INDUSTRY